Authors: Rothenberg, ML Kuhn, JG Schaaf, LJ Rodriguez, GI Eckhardt, SG Villalona-Calero, MA Rinaldi, DA Hammond, LA Hodges, S Sharma, A Elfring, GL Petit, RG Locker, PK Miller, LL von Hoff, DD

Citation: Ml. Rothenberg et al., Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks, ANN ONCOL, 12(11), 2001, pp. 1631-1641

Authors: Rinaldi, DA Lormand, NA Brierre, JE Cole, JL Stagg, MP Fontenot, MF Buller, EJ Rainey, JM

Citation: Da. Rinaldi et al., A phase I trial of gemcitabine and infusional 5-fluorouracil (5-FU) in patients with refractory solid tumors - Louisiana Oncology Associates protocolno. 1 (LOA-1), AM J CL ONC, 23(1), 2000, pp. 78-82

Authors: Hammond, LA Eckardt, JR Baker, SD Eckhardt, SG Dugan, M Forral, K Reidenberg, P Statkevich, P Weiss, GR Rinaldi, DA Von Hoff, DD Rowinsky, EK

Citation: La. Hammond et al., Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies, J CL ONCOL, 17(8), 1999, pp. 2604-2613

Authors: Rinaldi, DA Kuhn, JG Burris, HA Dorr, FA Rodriguez, G Eckhardt, SG Jones, S Woodworth, JR Baker, S Langley, C Mascorro, D Abrahams, T Von Hoff, DD

Citation: Da. Rinaldi et al., A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation, CANC CHEMOT, 44(5), 1999, pp. 372-380

Authors: Pazdur, R Royce, ME Rodriguez, GI Rinaldi, DA Patt, YZ Hoff, PM Burris, HA

Citation: R. Pazdur et al., Phase trial of docetaxel for cholangiocarcinoma, AM J CL ONC, 22(1), 1999, pp. 78-81

Authors: Rinaldi, DA

Citation: Da. Rinaldi, Overview of Phase I trials of multitargeted antifolate (MTA, LY231514), SEMIN ONCOL, 26(2), 1999, pp. 82-88